Jim Simons Renaissance Technologies
Jim Simons is the founder of Renaissance Technologies, one of the most successful quantitative hedge funds in the world. Before his career in finance, he served as a mathematics professor and made significant contributions to differential geometry. Simons applied his analytical expertise to develop sophisticated, algorithm-driven trading strategies, earning consistently high returns for investors.
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Zoom
ZM
|
+$806M |
| 2 |
AbbVie
ABBV
|
+$481M |
| 3 |
T-Mobile US
TMUS
|
+$464M |
| 4 |
Kroger
KR
|
+$430M |
| 5 |
Baidu
BIDU
|
+$423M |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$1.35B |
| 2 |
AGN
Allergan plc
AGN
|
+$1.26B |
| 3 |
S
Sprint Corporation
S
|
+$675M |
| 4 |
Amgen
AMGN
|
+$488M |
| 5 |
Humana
HUM
|
+$450M |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 23.76% |
| 2 | Technology | 16.41% |
| 3 | Consumer Staples | 10.58% |
| 4 | Consumer Discretionary | 10.13% |
| 5 | Communication Services | 9.97% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
2251
Knowles
KN
$3.29B
| $1.74M | ﹤0.01% |
114,000
-226,574
| -67% | -$3.38M |
|
2252
Team
TISI
$101M
| $1.74M | ﹤0.01% |
31,153
+20,404
| +190% | +$1.13M |
|
2253
NetSol Technologies
NTWK
$48.3M
| $1.73M | ﹤0.01% |
640,242
+96,118
| +18% | +$263K |
|
2254
Matthews International
MATW
$725M
| $1.73M | ﹤0.01% |
+90,353
| New | +$1.93M |
|
|
XOMA
2255
DELISTED
Xoma
XOMA
| $1.73M | ﹤0.01% |
87,369
-20,217
| -19% | -$444K |
|
|
TRTX
2256
TPG RE Finance Trust
TRTX
$609M
| $1.72M | ﹤0.01% |
200,317
-1,365,200
| -87% | -$9.92M |
|
|
WDR
2257
DELISTED
Waddell & Reed Financial, Inc.
WDR
| $1.72M | ﹤0.01% |
+111,000
| New | +$1.52M |
|
|
NM
2258
DELISTED
Navios Maritime Holdings Inc.
NM
| $1.71M | ﹤0.01% |
808,744
-8,200
| -1% | -$17.8K |
|
2259
Alector
ALEC
$219M
| $1.71M | ﹤0.01% |
+69,780
| New | +$1.93M |
|
2260
Schwab US Large- Cap ETF
SCHX
$74.9B
| $1.7M | ﹤0.01% |
138,000
+55,200
| +67% | +$643K |
|
2261
iShares Latin America 40 ETF
ILF
$3.71B
| $1.7M | ﹤0.01% |
78,800
+38,400
| +95% | +$772K |
|
|
TGA
2262
DELISTED
Transglobe Energy Corp
TGA
| $1.7M | ﹤0.01% |
2,971,467
+23,900
| +0.8% | +$12.4K |
|
|
OPNT
2263
DELISTED
Opiant Pharmaceuticals, Inc. Common Stock
OPNT
| $1.7M | ﹤0.01% |
187,970
+126,742
| +207% | +$1.31M |
|
2264
Eagle Bancorp
EGBN
$878M
| $1.7M | ﹤0.01% |
51,785
-31,200
| -38% | -$995K |
|
|
HTT
2265
High Templar Tech Ltd
HTT
$393M
| $1.7M | ﹤0.01% |
996,923
+62,830
| +7% | +$104K |
|
|
FCCY
2266
DELISTED
1st Constitution Bancorp
FCCY
| $1.69M | ﹤0.01% |
136,494
+1,724
| +1% | +$21.1K |
|
2267
Invesco China Technology ETF
CQQQ
$3.18B
| $1.69M | ﹤0.01% |
26,600
+13,300
| +100% | +$730K |
|
2268
Under Armour Class C
UA
$2.26B
| $1.68M | ﹤0.01% |
190,100
-1,455,543
| -88% | -$12.4M |
|
2269
Cytokinetics
CYTK
$10.3B
| $1.68M | ﹤0.01% |
+71,067
| New | +$1.33M |
|
2270
Caledonia Mining Corp
CMCL
$434M
| $1.67M | ﹤0.01% |
96,410
+84,910
| +738% | +$1.18M |
|
2271
World Kinect Corp
WKC
$1.85B
| $1.67M | ﹤0.01% |
64,773
-722,600
| -92% | -$17.8M |
|
|
HMNF
2272
DELISTED
HMN Financial Inc
HMNF
| $1.66M | ﹤0.01% |
114,000
+3,900
| +4% | +$59.4K |
|
2273
BellRing Brands
BRBR
$1.25B
| $1.66M | ﹤0.01% |
+83,400
| New | +$1.55M |
|
|
MLVF
2274
DELISTED
Malvern Bancorp, Inc.
MLVF
| $1.66M | ﹤0.01% |
130,164
+29,400
| +29% | +$347K |
|
2275
Hasbro
HAS
$13.6B
| $1.66M | ﹤0.01% |
22,100
-446,541
| -95% | -$32.3M |
|
Similar funds
Jim Simons's Q2 2020 Portfolio in Review
As of Q2 2020, Jim Simons held 3,987 positions worth $116B, up 13% from $103B the previous quarter. Its ten largest holdings account for 14% of the portfolio.
Jim Simons withdrew a net $8.24B in Q2 2020, closing 596 positions and reducing 1,366 holdings. Its most notable exit was Allergan plc, an estimated $1.26B position sold in full.
By sector, the portfolio is most concentrated in Healthcare at 24% of assets, down from 26% a quarter earlier, followed by Technology and Consumer Staples.
Against the trend, Jim Simons opened a new position in Uber worth $187M.
- Jim Simons's largest Q2 2020 buy was Uber: 6,030,316 shares worth $187M.
- Jim Simons added most to Zoom in Q2 2020, an estimated $806M increase.
- Jim Simons's biggest Q2 2020 reduction was Bristol-Myers Squibb, cutting an estimated $1.35B.
- Jim Simons fully exited Allergan plc in Q2 2020, selling an estimated $1.26B.
- Jim Simons's ten largest holdings make up 14% of its $116B portfolio in Q2 2020.
- Jim Simons opened 584 new positions and closed 596 in Q2 2020.
- Jim Simons's portfolio value rose 13% quarter-over-quarter to $116B.
Based on Renaissance Technologies's 13F filing for Q2 2020, filed 13 Aug 2020.